• Molecular Epidemiology of ALK Rearrangements in Advanced Lung Adenocarcinoma in Latin America 

    Arrieta O, Cardona AF, Bramuglia y col. Oncology 2019; 96:207-216. https://doi.org/10.1159/00049373

 

  • Estudio Multicéntrico: evaluación clínica e instrumental de la disfagia en pacientes adultos
Molinatti ME, Sanchez Valverde  M, Duek V, La Vía MB, Brotzman G
Revista FASO Año 26, No.1 2019
 
  • Rehabilitación vocal en un paciente con cáncer de laringe tratado con radioterapia
Sanchez Valverde M, Levin D, Brotzman G, pereira D. Zeballos G.
Revista FASO Año 25 No.2, 2018
 
  • Percusión, ritmo y movimiento: Facilitadores del proceso de rehabilitación del paciente laringectomizado
Somoza S,Williams M, Brotzman G, Sanchez Valverde M
Revista FASO Año 24 No.1, 2017
 
  • Disfagia Oncogénica post quimioradiotetrapia
Brotzman G, Sanchez Valverde M, Giglio R, Pereira D, Carrera JM, Adan R, Zund S, Delrieu Revista FASO Año 23, No. 3,2016

Ver publicación

 

  • Expression of bladder cancer-associated glycans in murine tumor cell lines.

Albertó M, Cuello HA, Gulino CA, Pifano M, Belgorosky D, Gabri MR, Eiján AM, Segatori VI. Oncol Lett. 2019 Mar;17(3):3141-3150. doi: 10.3892/ol.2019.9995.

  • Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth

Ferragut F, Cagnoni AJ, Colombo LL, Sánchez Terrero C, Wolfenstein-Todel C, Troncoso MF, Vanzulli SI, Rabinovich GA, Mariño KV, Elola MT.
Biochem Biophys Acta Mol Cell Res. 2019 Mar 21. pii:S0167-4889(19)30035-7. doi: 10.1016/j.bbamcr.2019.03.010
.

  • Translational boron neutron capture therapy (BNCT) studies for the treatment of tumors in lung.

Trivillin VA, Serrano A, Garabalino MA, Colombo LL, Pozzi EC, Hughes AM, Curotto PM, Thorp SI, Farías RO, González SJ, Bortolussi S, AltieriS, Itoiz ME, Aromando RF, Nigg DW, Schwint AE.

IntJ Radiat Biol. 2019 Jan 2:1-9. doi: 10.1080/09553002.2019.

  • Combination of cytokine-enhanced vaccine and chemo-gene therapy as surgery adjuvant treatments for spontaneous canine melanoma

Finocchiaro LME, Agnetti L, Fondello C, Glikin GC. GeneTher. 2019 Mar 11. doi: 10.1038/s41434-019-0066-7.

  • Analysis of tumoral spheres growing in a multichamber microfluidic device.

Belgorosky D, Fernández-Cabada T, Peñaherrera-Pazmiño AB, Langle Y, Booth R, Bhansali S, Pérez MS, Eiján AM, Lerner B. J Cell Physiol. 2018 Sep;233(9):6327-6336. doi: 10.1002/jcp.26519.

  • Flavonoidsilybin improves the response to radiotherapy in invasive bladder cancer.

Prack Mc Cormick B, Langle Y, Belgorosky D, Vanzulli S, Balarino N, Sandes E, Eiján AM. J Cell Biochem. 2018 Jul;119(7):5402-5412. doi: 10.1002/jcb.26693.820

  • Coronin 1C promotes triple-negative breast cancer invasiveness through regulation of MT1-MMP traffic and invadopodia function.

Castagnino A, Castro-Castro A, Irondelle M, Guichard A, Lodillinsky C, Fuhrmann L, Vacher S, Agüera-González S, Zagryazhskaya-Masson A, Romao M, El Kesrouani C, Noegel AA, Dubois T, Raposo G, Bear JE, Clemen CS,Vincent-Salomon A, Bièche I, Chavrier P. Oncogene. 2018 Dec;37(50):6425-6441. doi: 10.1038/s41388-018-0422-x.

  • Outcomes of patients with bone metastases from differentiated thyroid cancer.

CalifanoI, Deutsch S, Cabezón C, Lowenstein A, Pitoia F. Arch Endocrinol Metab 2018, 62; 14-20.

  • Metástasis de carcinoma diferenciado de tiroides en localizaciones  infrecuentes: serie de 30 pacientes.

ZuninoA, Pitoia F, Faure E, Reyes A, Sala M, Sklate R,  Ilera V, Califano I. Rev Arg Endocrinol Metab, 2018, 55 (3); 144-149

  • Comparación de la respuesta inicial luego de la ablación con 30 mCi versus no ablación en pacientes con cáncer diferenciado de tiroides de bajo riesgo de recurrencia. Estudio prospectivo multicéntrico.

PitoiaF, Ilera V, Vázquez A, Faure E, Cavallo A, Califano I. Rev Arg Endocrinol Metab, 2018, 55 (3); 137142

http://www.raem.org.ar/numeros/2018-vol55/numero-03/vol55-03-001.pdf

  • AhR ligand aminoflavone suppresses α6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells.

CampbellPS, Mavingire N, Khan S, Rowland LK, Wooten JV, Opoku-Agyeman A,Guevara A, Soto U, Cavalli F, Loaiza-PérezAI, Nagaraj G, Denham LJ, Adeoye O, Jenkins BD, Davis MB, Schiff R, Brantley EJ. J Cell Physiol.2018 Jan;234(1):108-121. doi: 10.1002/jcp.27013. Epub 2018 Aug 4. PMID: 30076704

https://www.ncbi.nlm.nih.gov/pubmed/30076704

  • N4 -aryl substituted thiosemicarbazones derived from 1-indanones as potential anti-tumor agents for breast cancer treatment.

Sólimo A, Soraires Santacruz MC, Loaiza Perez AI, Bal de Kier Joffé E, Finkielsztein LM, Callero MA. J Cell Physiol. 2018 Jun;233(6):4677-4687. doi: 10.1002/jcp.26240.

https://www.ncbi.nlm.nih.gov/pubmed/29111571

  • NIR laser pointer for in vivo photothermal therapy of murine LM3 tumor using intratumoral China ink as a photothermal agent.

Blázquez-Castro A, Colombo LL, Vanzulli SI, Stockert JC. Lasers Med Sci. 2018 Aug;33(6):1307-1315. doi:10.1007/s10103-018-2483-

https://www.ncbi.nlm.nih.gov/pubmed/29549555

  • Tetrazolium salts and formazan products in Cell Biology: Viability assessment, fluorescence imaging, and labeling perspectives.

Stockert JC, Horobin RW, Colombo LL, Blázquez-Castro A. Acta Histochem. 2018 Apr;120(3):159-167. doi: 10.1016/j.acthis.2018.02.005.

https://www.ncbi.nlm.nih.gov/pubmed/29496266

  • The inflammatory cytokine TNF contributes with RAC3-induced malignant transformation.

Machado MS, Rosa FD, Lira MC, Urtreger AJ, Rubio MF, Costas MA. EXCLI J. 2018 Nov 2;17:1030-1042. doi: 10.17179/excli2018-1759.

https://www.ncbi.nlm.nih.gov/pubmed/30585274

  • Signaling network involved in the GPC3-induced inhibition of breast cancer progression: role of canonical Wnt pathway.

Fernández D, Guereño M, Lago Huvelle MA, Cercato M, Peters MG. J Cancer Res Clin Oncol. 2018 Dec;144(12):2399-2418. doi:10.1007/s00432-018-2751-0.

https://www.ncbi.nlm.nih.gov/pubmed/30267212

  • Production of biologically active feline interferon beta in insect larvae using a recombinant baculovirus.

Arregui MB, Mc Callum GJ, Smith I, Villaverde MS, Wolman FJ, Targovnik AM, Miranda MV. Biotech. 2018 Aug;8(8):341. doi: 10.1007/s13205-018-1369-x.
https://www.ncbi.nlm.nih.gov/pubmed/30073126

  • Combination of Suicide and Cytokine Gene Therapies as Surgery Adjuvant for Canine Mammary Carcinoma.

Finocchiaro LME, Spector AIM, Agnetti L, Arbe MF, Glikin GC. VetSci. 2018 Aug 3;5(3). pii: E70. doi: 10.3390/vetsci5030070.

https://www.ncbi.nlm.nih.gov/pubmed/30081470

  • Mechanisms Enhancing the Cytotoxic Effects of Bleomycin plus Suicide or Interferon-β Gene Lipofection in Metastatic Human Melanoma Cells.

Fondello C, Agnetti L, Glikin GC, Finocchiaro LME. Anticancer
Agents Med Chem. 2018;18(9):1338-1348. doi:10.2174/1871520618666180604084849
.

https://www.ncbi.nlm.nih.gov/pubmed/29866016

  • Genomic analysis of head and neck cancer cases from two high incidence regions.

Perdomo S, Anantharaman D, Foll M, Abedi-Ardekani B, Durand G, Reis Rosa LA,Holmila R, Le Calvez-Kelm F, Tajara EH, Wünsch-Filho V, Levi JE,
Vilensky M, Polesel J, Holcatova I, Simonato L, Canova C, Lagiou P, McKay JD, Brennan P. PLoS One. 2018 Jan 29;13(1): e0191701. doi:
10.1371/journal.pone.0191701.

https://www.ncbi.nlm.nih.gov/pubmed/29377909

  • Circulating tumor DNA detection in head and neck cancer: evaluation of two different detection approaches.

Perdomo S, Avogbe PH, Foll M, Abedi-Ardekani B, Facciolla VL, Anantharaman D, Chopard P, Calvez-Kelm FL, Vilensky M, Polesel J, Holcatova I, Simonato L, Canova C, Lagiou P, McKay JD, Brennan P. Oncotarget. 2017 Aug 7;8(42):72621-72632. doi: 10.18632/oncotarget.20004.

https://www.ncbi.nlm.nih.gov/pubmed/29069814

  • Bacillus Calmette-Guerin improves local and systemic response to radiotherapy in invasive bladder cancer.

Prack Mc Cormick B, Belgorosky D, Langle Y, Balarino N, Sandes E, Eiján
AM. Nitric Oxide. 2017 Apr 1;64:22-30. doi: 10.1016/j.niox.2017.01.008.

https://www.ncbi.nlm.nih.gov/pubmed/28126499

  • Bacillus Calmette-Guerin improves local and systemic response to radiotherapy in invasive bladder cancer.

Prack Mc Cormick B, Belgorosky D, Langle Y, Balarino N, Sandes E, Eiján
AM. Nitric Oxide. 2017 Apr 1;64:22-30. doi: 10.1016/j.niox.2017.01.008.

https://www.ncbi.nlm.nih.gov/pubmed/28126499

  • In Vitro Antitumor Effects of AHR Ligands Aminoflavone (AFP 464) and Benzothiazole (5F 203) in Human Renal Carcinoma Cells.

Luzzani GA, Callero MA, Kuruppu AI, Trapani V, Flumian C, Todaro L, Bradshaw TD, Loaiza Perez AI. J Cell Biochem. 2017 Dec;118(12):4526-4535. doi: 10.1002/jcb.26114.

https://www.ncbi.nlm.nih.gov/pubmed/28471540

  • The Immune System as a New Possible Cell Target for AFP 464 in a
    Spontaneous Mammary Cancer Mouse Model.

Callerom MA, Rodriguez CE, Sólimo A, Bal de Kier Joffé E, Loaiza Perez AI.J
Cell Biochem. 2017 Sep;118(9):2841-2849. doi: 10.1002/jcb.25934.

https://www.ncbi.nlm.nih.gov/pubmed/28206673

  • Abscopal effect of boron neutron capture therapy (BNCT): proof of principle in an experimental model of colon cancer.

Trivillin VA, Pozzi ECC, Colombo LL, Thorp SI, Garabalino MA, Monti Hughes A, González SJ, Farías RO, Curotto P, Santa Cruz GA, Carando DG,
Schwint AE. Radiat Environ Biophys. 2017 Nov;56(4):365-375. doi: 10.1007/s00411-017-0704-7.

https://www.ncbi.nlm.nih.gov/pubmed/28791476

  • High RAC3 expression levels are required for induction and maintaining of cancer cell stemness.

Panelo LC, Machado MS, Rubio MF, Jaworski F, Alvarado CV, Paz LA, Urtreger AJ, Vazquez E, Costas MA. Oncotarget. 2017 Dec 22;9(5):5848-5860. doi: 10.18632/oncotarget.23635.

https://www.ncbi.nlm.nih.gov/pubmed/29464039

  • The synthetic peptide CIGB-300 modulates CK2-dependent signaling pathways affecting the survival and chemoresistance of non-small cell lung cancer cell lines.

Cirigliano SM, Díaz Bessone MI, Berardi DE, Flumian C, Bal de Kier Joffé ED,
Perea SE, Farina HG, Todaro LB, Urtreger AJ. Cancer Cell Int. 2017 Mar 31;17:42. doi: 10.1186/s12935-017-0413-y.

https://www.ncbi.nlm.nih.gov/pubmed/28373828

  • Laminin Modulates the Stem Cell Population in LM05-E Murine Breast Cancer Cells through the Activation of the MAPK/ERK Pathway.

Berardi DE, Raffo D, Todaro LB, Simian M Cancer

Res Treat. 2017 Oct;49(4):869-879. doi: 10.4143/crt.2016.378.

https://www.ncbi.nlm.nih.gov/pubmed/28052658

  • Therapeutic potential of bleomycin plus suicide or interferon-β gene transfer combination for spontaneous feline and canine melanoma.

Agnetti L, Fondello C, Villaverde MS, Glikin GC, Finocchiaro LME.

Oncoscience. 2017 Dec 28;4(11-12):199-214. doi: 10.18632/oncoscience.387.

  • Inhibition of bioenergetic metabolism by the combination of metformin and 2-deoxyglucose highly decreases viability of feline mammary carcinoma cells.

Arbe MF, Fondello C, Agnetti L, Álvarez GM, Tellado MN, Glikin GC,
Finocchiaro LME, Villaverde MS.

Res Vet Sci. 2017 Oct;114:461-468. doi: 10.1016/j.rvsc.2017.07.035.